PMID: 26816606DOI: 10.1111/jdi.12373Jan 28, 2016Paper
Efficacy and safety of insulin degludec in Japanese patients with type 1 and type 2 diabetes: 24-week results from the observational study in routine clinical practice
Journal of Diabetes Investigation
Kazuhiro KobukeGenshi Egusa
Abstract
This is first observational prospective study of insulin degludec in routine clinical practice that we evaluated the effect on glycemic control and risk of hypoglycemia in basal-bolus insulin therapy. We found that insulin degludec can maintain glycemic control at a lower insulin dose and frequency of hypoglycemia in type 1 diabetes, while it can improve glycemic control at equally insulin dose in type 2 diabetes. These results mean that insulin degludec is of use in routine clinical practice.
References
Jul 24, 2002·Diabetologia·P E Cryer
Jan 12, 2005·Diabetes, Obesity & Metabolism·I De LeeuwJ W F Elte
Feb 23, 2007·International Journal of Clinical Practice·A DornhorstL Landstedt-Hallin
Apr 5, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·P C BartleyA Philotheou
Jun 10, 2008·The New England Journal of Medicine·Anushka PatelFlorence Travert
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Oct 24, 2008·Diabetes Care·Jean-Pierre Le FlochUNKNOWN Assessment of Detemir Administration in Progressive Treat-to-Target Trial (ADAPT) Study Group
Dec 19, 2008·The New England Journal of Medicine·William DuckworthUNKNOWN VADT Investigators
Sep 15, 2009·Diabetes Research and Clinical Practice·Leo NiskanenTero Saukkonen
Jan 14, 2011·Diabetes Care·UNKNOWN American Diabetes Association
Jun 3, 2011·Diabetologia·B F HansenD Russell-Jones
Feb 9, 2012·Journal of Medical Economics·Hitoshi Ishii
Apr 10, 2012·Pharmaceutical Research·Ib JonassenUlla Ribel
Apr 24, 2012·Lancet·Simon HellerUNKNOWN BEGIN Basal-Bolus Type 1 Trial Investigators
Apr 24, 2012·Lancet·Alan J GarberUNKNOWN NN1250-3582 (BEGIN BB T2D) Trial Investigators
May 19, 2012·Diabetes, Obesity & Metabolism·T HeiseH Haahr
Oct 9, 2012·Diabetes Care·Bernard ZinmanUNKNOWN NN1250-3579 (BEGIN Once Long) Trial Investigators
Dec 4, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·N FreemantleR Ratner
Feb 9, 2013·The Journal of Clinical Endocrinology and Metabolism·Chantal MathieuStephen C Bain
May 29, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·B W BodeUNKNOWN BEGIN® Basal-Bolus Type 1 trial investigators
Aug 21, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·H W RodbardUNKNOWN BEGIN Once Long trial investigators
Nov 28, 2013·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Yoshiki KusunokiMitsuyoshi Namba
❮ Previous
Next ❯
Citations
May 18, 2016·Journal of Diabetes Investigation·Seiya ShimodaUNKNOWN Kumamoto Insulin Degludec Observational (KIDUNA) Study Group
Jul 11, 2018·Journal of Diabetes Investigation·Mizuho YamabeMasayasu Yoneda
Oct 28, 2019·Diabetes/metabolism Research and Reviews·Morten Hasselstrøm JensenPeter Vestergaard
Feb 22, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Daniela Sofra
Aug 3, 2018·International Journal of Pediatric Endocrinology·Inderpal Singh Kochar, Aashish Sethi
Jun 21, 2018·International Journal of Clinical Practice·Maria Dolores Garcia de LucasBeatriz Aviles Bueno
May 30, 2016·Diabetology International·Jun SuzukiYasuo Terauchi
Aug 10, 2019·The Journal of Clinical Endocrinology and Metabolism·Gian Paolo FadiniJohan Jendle
Oct 5, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Gian Paolo FadiniUNKNOWN REFLECT Italian Study Group
Jan 5, 2021·Endocrine Journal·Mitsuhisa KomatsuTakashi Kadowaki
May 13, 2021·Adipocyte·Xiaorui LyuFengying Gong
May 29, 2021·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Shuhei NakanishiHideaki Kaneto
❮ Previous
Next ❯
Related Concepts
Related Feeds
Autoimmune Diabetes & Tolerance
Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.
Related Papers
Current Medical Research and Opinion
Anne DornhorstPREDICTIVE Study Group
Journal of the American Association of Nurse Practitioners
Bridget Jackson, Laurie Grubbs
Nature Clinical Practice. Endocrinology & Metabolism
Merri Pendergrass
Diabetic Medicine : a Journal of the British Diabetic Association
Bruce W BodeBEGIN® Basal-Bolus Type 1 trial investigators
Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición
Emilio García-GarcíaAntonio Bonillo